AgomAb Therapeutics NV (NASDAQ:AGMB) IPO

AgomAb Therapeutics NV

IPO

Priced at US$16.00 an ADS on Feb 5, 2026.

Price
US$16.00 an ADS
Offering size
US$200 million
Underwriters' option
Up to 1,875,000 more ADSs
Listing
AGMB on the Nasdaq Global Select Market
Underwriters
J.P. Morgan, Morgan Stanley, Leerink Partners, Van Lanschot Kempen · In the order on the cover

Steps

StepWhen
Draft sent to the SEC in confidenceJun 20, 2024
Filed publiclyJan 16, 2026
Amended onceJan 29, 2026
Declared effective by the SECJan 30, 2026
Shares registered with an exchangeFeb 3, 2026
Final prospectus, with the priceFeb 6, 2026

From the cover of the final prospectus (424B4) filed Feb 6, 2026